A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group

A recent meta-analysis and randomized studies have demonstrated that combined chemoradiotherapy is associated with a survival advantage for selected patients with locally advanced unresectable non-small-cell lung cancer (NSCLC). We conducted a phase II study of combined chemoradiotherapy to find a m...

Descripción completa

Detalles Bibliográficos
Autores principales: Segawa, Y, Ueoka, H, Kiura, K, Kamei, H, Tabata, M, Sakae, K, Hiraki, Y, Kawahara, S, Eguchi, K, Hiraki, S, Harada for the Okayama Lung Cancer Study Group, Mine
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363201/
https://www.ncbi.nlm.nih.gov/pubmed/10638975
http://dx.doi.org/10.1054/bjoc.1999.0885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363201/
https://www.ncbi.nlm.nih.gov/pubmed/10638975
http://dx.doi.org/10.1054/bjoc.1999.0885

Ejemplares similares